Introduction
Although peripheral neuropathy is probably the commonest long-term complication of diabetes (Ellenberg, 1982) , little is known of its natural history and prognosis. The few reported'studies have produced conflicting results (Fry, Hardwich and Scott, 1962;  Mayne, 1968; Bischoff, 1981) and, have usually involved all groups of neuropathy, including mononeuropathy and autonomic neuropathy. These different conditions may have a variable prognosis (Ellenberg, 1982; Thomas, Ward and Watkins, 1982; Ewing, Campbell and Clarke, 1976) . Since the commonest manifestation is painful peripheral neuropathy of the lower limbs, we have identified and followed 39 patients with these symptoms in order to determine the natural history of this condition.
Materials and methods
Thirty-nine patients (29 males) with sensorimotor diabetic neuropathy were selected for study between 1976 and 1978 . There were 12 insulin-dependent diabetics and 27 non-insulin-dependent diabetics, mean age 55-5 years (range 40-72 years) and duration of diabetes 10-9 years (range 1-34 years). All subjects were outpatients, were assessed independently by 2 investigators before their selection, and satisfied the following strict criteria for diagnosis of neuropathy:-(1) Painful symptoms in both legs for at least 12 months before the study. All (Yao, Hobbs and Irvin, 1969) .
In addition, none had a history of alcohol abuse (McCulloch et al., 1980) and all had a haemoglobin greater than 12 g/dl. Other diabetic complications were present in 14 patients: 10 had background retinopathy and 4 had proliferative changes.
All subjects were asked to score their painful symptoms on a 10 cm horizontal graphic rating scale (no pain = 0; maximum pain= 10) (Scott and Huskisson, 1976 ). This scale consists of a 10 cm horizontal straight line, each end representing the extreme, either maximum symptoms or no symptoms. Subjects were asked to mark the scale at a point corresponding with their symptoms. The point was then measured, giving a score of between 0 and 10; the higher the score the more severe the symptoms. The same pain scale was used for the follow-up appointment, so that any change in symptoms could be indicated by the patient. Motor conduction velocities (MCV) were measured in the right median and peroneal nerves as previously described (Ward et al., 1971) , and the ankle pressure index, the ratio of posterior tibial systolic pressure to brachial systolic pressure was recorded using a Doppler ultrasound stethoscope (Yao et al, 1969 ). The subjects were followed for a mean period of 4-7 years (range 2-5 years) during which they continued to attend the diabetic clinic. 
Results
The results of the investigations are summarised in Table 1 . No significant changes in symptom scores were found during the 4-year study and furthermore, no subject experienced complete resolution of symptoms, though some improvement was noted by 11 subjects (Fig. 1) . There was no significant difference between the clinic blood glucose levels in the subjects who experienced improvement of symptoms during the study (9-7 mmol/litre + 2.6), when compared with those experiencing no changes in symptoms (9-8 mmol/litre 2-4), or worsening of symptoms (10-2 mmol/litre ± 2-3). Moreover (Bischoff, 1981) . In an earlier study, Fry et al. (1962) reported 39 patients with symmetrical neuropathy, and concluded that only one-third of patients showed a satisfactory improvement. Conversely, Mayne (1968) , in his series of 73 patients followed for an average of 3 years, concluded that symptoms of neuropathy tended to improve. However, in these 3 earlier studies subjects with peripheral neuropathy were grouped with other patients suffering from mononeuropathy and autonomic dysfunction. A follow-up of such a broad group may well produce conflicting results, as the mononeuropathies have been shown to carry a good prognosis (Ellenberg, 1982; Thomas et al., 1982) , whereas Ewing et al. (1976) have demonstrated that established autonomic neuropathy carries a significant mortality. Furthermore, these earlier studies used questionnaires and interviews to assess the severity of symptoms. We chose to use the most reliable, semiquantitative method available to assess changes in symptoms (Scott and Huskisson, 1976) . (Archer et al., 1982) established neuropathic symptoms do not resolve spontaneously and may persist for many years. Although 11 of our subjects noted some improvement (Fig. 1) Ward et al., 1981) , the present study probably reflects the natural history of this condition. Despite strict selection criteria, several patients developed symptoms and signs of peripheral vascular disease. The differentiation between neuropathic and vascular symptoms can be very difficult (Ward, 1982) and even an ankle pressure index of greater than unity does not necessarily exclude patients with early large vessel disease (Boulton et al., 1981) . Earlier studies have stressed the importance of diabetic control in the management of peripheral neuropathy (Goodman et al., 1953; Fry et al., 1962; Mayne, 1968) , but methods of assessment of control in such studies are now known to be suspect (Molnar et al., 1979 Dornan, Mann and Turner (1982) . From such results, it is apparent that, in the present study, there was no significant difference in control between groups that showed improvement, deterioration or no change in symptoms. Boulton et al. (1982a,b) have recently confirmed the importance of strict glycaemic control in the aetiology and management of neuropathy using more valid measurements of control. However, no group in the present study achieved near normalisation of blood glucose as reported by Boulton et al. (1982b) . Thus, though we conclude that symptoms of diabetic neuropathy frequently persist for several years, recent studies suggest that glycaemic control may offer symptomatic relief to such patients. Further similar longitudinal studies with strict blood glucose control are now required.
